P E Goss - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P E Goss

Showing results (71-80 of 73) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 73 results.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 3, 2012

Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozoleP E Goss, J N Ingle, S Martino, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017

Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trialsR Yerushalmi, B Dong, J W Chapman, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2008

Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17J N Ingle, D Tu, J L Pater, et al.

Pageof 8

Search research articles

Showing results (71-80 of 73) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 73 results.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 3, 2012

Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozoleP E Goss, J N Ingle, S Martino, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017

Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trialsR Yerushalmi, B Dong, J W Chapman, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2008

Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17J N Ingle, D Tu, J L Pater, et al.

Pageof 8